NEW! Investment Companies Centre

Fulcrum (FUL)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE AIM All-Share

Market Cap

£5.34m

Change Today

Price Unchanged0.000p ()

Share Price

3.00p

Fulcrum outlines strong trading at Quadramed

Date: Wednesday 21 Feb 2007

LONDON (ShareCast) - Shares in drug development group Fulcrum Pharma rose after it said it will make the maximum deferred payment of £500,000 in convertible loan notes to recently acquired Quadramed, after its 'strong' performance.

In a statement Fulcrum said trading at Quadramed had been better than expected with its fee income expected to be 50% more than a year ago.

Fulcrum chief executive Jon Court said, "I am very pleased with the
success of the Quadramed acquisition. The further expansion of the Edinburgh office will enable our business to increase both the range of its services and the volume of work for our international client base."

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Fulcrum Market Data

Currency UK Pounds
Share Price 3.00p  
Closing Price Change 0.000p
52 Week High 3.75
52 Week Low 2.13
Volume 23,861
Shares Issued 177.94m
Market Cap £5.34m
RiskGrade 498

Performance Indicators

Compare performance with the sector and the market.
Find out more
Key: vs Market vs Sector
Value
43.38% above the market average43.38% above the market average43.38% above the market average43.38% above the market average43.38% above the market average
92.21% above the sector average92.21% above the sector average92.21% above the sector average92.21% above the sector average92.21% above the sector average
Price Trend
61.39% above the market average61.39% above the market average61.39% above the market average61.39% above the market average61.39% above the market average
60.92% above the sector average60.92% above the sector average60.92% above the sector average60.92% above the sector average60.92% above the sector average
Income Not Available
Growth
82.05% above the market average82.05% above the market average82.05% above the market average82.05% above the market average82.05% above the market average
83.10% above the sector average83.10% above the sector average83.10% above the sector average83.10% above the sector average83.10% above the sector average
Price Chg 6m
55.79% above the market average55.79% above the market average55.79% above the market average55.79% above the market average55.79% above the market average
54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average
P/E
49.2% below the market average49.2% below the market average49.2% below the market average49.2% below the market average49.2% below the market average
5.26% above the sector average5.26% above the sector average5.26% above the sector average5.26% above the sector average5.26% above the sector average
PEG
20.93% above the market average20.93% above the market average20.93% above the market average20.93% above the market average20.93% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Dividend Yield Not Available
EPS Growth
74.48% above the market average74.48% above the market average74.48% above the market average74.48% above the market average74.48% above the market average
38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average38.46% above the sector average
Operating Margin
15.73% below the market average15.73% below the market average15.73% below the market average15.73% below the market average15.73% below the market average
54.05% above the sector average54.05% above the sector average54.05% above the sector average54.05% above the sector average54.05% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Fulcrum Dividends

  Latest Previous
  Interim Interim
Ex-Div 26-May-04 28-May-03
Paid 25-Jun-04 27-Jun-03
Amount 0.20p 0.20p

Trades for --2008

Time Volume / Share Price
0 @ 0.000p

Fulcrum Key Personnel

CEO Frank Armstrong

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).